Cutibacterium Acnes: Triple Prevention in Shoulder Operations

Launched by CLINIQUE GÉNÉRALE DANNECY · Jan 18, 2023

Keywords

ClinConnect Summary

This clinical trial is studying ways to prevent infections after shoulder surgery, specifically looking at a type of bacteria called Cutibacterium Acnes. Patients who are scheduled for any type of shoulder surgery, including both arthroscopic and open procedures, may be eligible to participate. To qualify, they should not have had shoulder surgery before, must not have a recent shoulder infection, and should not be currently taking antibiotics.

Participants in the trial will be randomly assigned to one of three groups. One group will receive a standard skin cleaning before surgery, while the second group will have a more thorough skin cleaning. The third group will get both types of cleaning and also use a special gel on their skin in the days leading up to surgery. During the surgery, samples will be taken to check for the presence of Cutibacterium Acnes. The main goal is to see which method is most effective in reducing this bacteria and potentially preventing infections. If you're interested in participating, this could be an opportunity to contribute to important research while receiving careful monitoring during your surgical procedure.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Indication for all types of surgery at the shoulder joint, acromioclavicular joint, or clavicle, including arthroscopic and open surgery.
• Exclusion Criteria:
• • Previous shoulder surgery;
• • History of shoulder infection;
• • Antibiotic treatment in the last 6 weeks;
• • Allergy or hypersensitivity to one of the disinfecting agents;
• • Patients with laboratory values consistent with a current infection (C-reactive protein, erythrocyte sedimentation rate, leukocyte count).